Back

Cardiorenal syndrome in German primary care: real-world diagnostics and SGLT2 Inhibitor use

31 August 2026 (13:15 - 13:25)
Organised by: Logo
Congress Presentation Part of: Advanced cardiorenal disease in clinical practice: implementation, interventions, and prognosis Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Associate Professor Sven Wassmann

Cardiology Pasing, Munich (Germany)

5 More presentations in this session

Presentation thumbnail
PEN2 stabilizes SLC25A51 to inhibit vascular calcification through NAD+ redistribution between mitochondrion and nucleus
Assistant Professor B. Dong (CN)
Abstract Slides Video
Presentation thumbnail
Effects on albuminuria and blood pressure after radiofrequency renal denervation: two-year results from the Global SYMPLICITY Registry DEFINE
Professor M. Schlaich (Perth, AU)
Abstract Slides Video
Presentation thumbnail
Association of the non–lipoprotein(a) apolipoprotein b–to–lipoprotein(a) ratio with renal dysfunction in cardiovascular disease patients: implications for atherosclerotic burden and prognosis
Doctor K. Yamamoto (JP)
Abstract Slides Video
Presentation thumbnail
Nationwide 5-year outcomes in U.S. dialysis patients with failed bioprosthetic surgical AVR: valve-in-valve TAVR versus redo surgery
Doctor M. Tagliafierro (New York, US)
Abstract Slides Video
Presentation thumbnail
Clinical profile and determinants of NECPAL positivity in advanced cardiorenal syndrome: a prospective multicentre study
Doctor I. Navarro-Pelayo Torres (Granada, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Advanced cardiorenal disease in clinical practice: implementation, interventions, and prognosis
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
WATCH HF Awareness of prevalence, diagnosis and treatment of chronic heart failure in at risk patients in german primary care analysing real world data of chronic HF management in Germany
1 September 2025
thumbnail
Congress Presentation
Persistent gender differences in the management of chronic kidney disease in patients with heart failure – follow-up of the InspeCKD study
28 August 2026
thumbnail
Congress Presentation
Care discrepancy in the management of the cardiorenal-metabolic syndrome: real-world analysis of SGLT2 inhibitor use in heart failure, chronic kidney disease, and type 2 diabetes
10 May 2026
thumbnail
Congress Session
Further Insights into SGLT2i treatment for heart failure
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources